🧠 You can shrink the tumour—but not the tumour bed. New RAPIDO analysis in BJS 2025 shows why small margins after TNT can turn dangerous 👇 💡 Trial: RAPIDO (n = 920, LARC) 🎯 TNT = 5×5 Gy + 6 CAPOX / 9 FOLFOX → TME vs CRT = 25–28×1.8–2 Gy + capecitabine → TME 📊 8-year

Is Minimally Invasive Surgery at an Inflection Point?

#Rise of the #Robots 🦾 in the Netherlands 🇳🇱 GI surgery @AnnalsofSurgery 😳 How does this compare to your country? Data? Nationwide use 🦾 per organ among 77,361 resections (2014-2023): ✅ pancreas 1% to 33% ✅ thoracic 3% to 11% ✅ colon 6% to 14% ✅ rectum 19% to 45% ✅

Interesting paper questioning the need for routine type and screen by @KhanSidrah786 from her year at @MayoClinicSurg colorectal surgery fellowship

Which pts undergoing elective colorectal resections need a preop type & screen? Find out exclusively in #DCRJournal:

RA-CUSUM charts offer a powerful tool to track surgeon performance in rectal cancer cases—spotting trends in complications, operative time, and outcomes in real time. https://t.co/Rjiyhw3gTQ

This study shows how RA-CUSUM can identify high and low outliers in robotic rectal surgery—offering a data-driven path to continuous surgical improvement. https://t.co/Rjiyhw3gTQ

For the 36th consecutive year since U.S. News & World Report launched its "Best Hospitals" rankings, Mayo Clinic again ranks at the top of the 2025–2026 list. Read more: https://t.co/mVhFe0Np7A

For dMMR colon cancer, FOLFOX + atezolizumab per ATOMIC is now incorporated into the NCCN Guidelines. @MayoCancerCare @ALLIANCE_org @ASCOPost @CCAlliance @RueschCenter @FightCRC

Great work team @JyiChengNg @RichardSassun @AnnaclaraS65 @MayoClinic @MayoCancerCare @MayoClinicSurg

Vacation: #sailing with Capt Marco in #Sardinia fantastic water, beaches, mountains, food and Friends. @DFerrariMD @RichardSassun @tommyv1992 @EricaCento

Safe Same-Day and Short-Stay Stoma Closures Revolutionize Care by Ferrari D, Violante T (...) Larson DW et 7 al. in J Gastrointest Surg 🪡 read our summary 👉 https://t.co/3FezoUcaGO 📖 read the article:

Spectacular wedding of Roberta and Tommaso in #sardinia. To my friend and colleague may your marriage be blessed and your new surgical practice in Bologna equally blessed. Love and respect to @tommyv1992 @DFerrariMD @EricaCento @AnnaclaraS65 @RichardSassun

Game-changer at #ASCO25 🔥 Pre-plenary press release!! ATOMIC is the most important adjuvant study yet for MSI-H colon cancer—and it’s practice-changing. 🧬 Stage III dMMR colon cancer 🧪 Atezolizumab + mFOLFOX6 vs mFOLFOX6 alone 💥 3-yr DFS: 86.4% vs 76.6% ⚖️ HR 0.50 | p <

If this were a pill, we’d call it revolutionary. It would headline plenaries, get FDA priority review, and cost $10,000 a month. Instead—it’s structured exercise. 🆕 NEJM June 2025 | CHALLENGE Trial Stage II–III colon cancer patients post-chemo (n=889) 📦 RCT of 3 years of

Congratulations to our team. Next chapter in Nonoperative Management of Mismatch Repair–Deficient Tumors | New England Journal of Medicine

Sassun-Mayo N/tumor, lymph node, and metastasis staging provided superior overall survival stratification vs the current @AJCCancer staging. https://t.co/Rnv0PFkJAJ @DrDavidLarson @RichardSassun @AnnaclaraS65 @NPMcKenna

Very proud of @BoutrosMarylise and @Garfinkle_R and honored to be part of this important collaboration @AmerSurg @AnnalsofSurgery #AmsrSurg2025

Couldn't stop thinking about the bizarre AI mangled images that have been atop the WTA website for the last 12 hours and counting, so I wrote about them here. Free to read, human-made writing here, but please do subscribe! https://t.co/9NLZYTHim0

Congrats to @JyiChengNg (a rising resident in GS at Hopkins!) for helping to define a significant improvement to prognostics in #Rectal #Cancer. https://t.co/GNvaJUvBN2 @MayoClinic @MayoCancerCare